The following formula illustrates how CMS would calculate the benchmark period manufacturer price for a Part D rebatable drug with a payment amount benchmark period identified under proposed 428.202(c)(1), as proposed in 428.202(d)(1): (AMP for calendar quarter beginning January 2021) multiplied by (sum of monthly AMP units for January 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning April 2021) multiplied by (sum of monthly AMP units for April 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning July 2021) multiplied by (sum of monthly AMP units for July 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) For a Part D rebatable drug with a payment amount benchmark period identified under proposed 428.202(c)(2) through (5), the following formula illustrates how CMS would calculate the benchmark period manufacturer price for a Part D rebatable drug as proposed in 428.202(d)(2): (AMP for calendar quarter beginning January) multiplied by (sum of monthly AMP units for January calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning April) multiplied by (sum of monthly AMP units for April calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning July) multiplied by (sum of monthly AMP units for July calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning October) multiplied by (sum of monthly AMP units for October calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) (4) Identification of the Benchmark Period CPI-U To calculate the inflation-adjusted payment amount in accordance with section 1860D-14B(b)(3), CMS must identify the benchmark period CPI-U
In nature, the root soaks up moisture to supply the bush in the dry times and it takes in the moisture that comes from burning tobacco as well
For the examination of the chemical contents of SLT products, gas chromatography (GC) with various detectors (Flame Ionization, Mass detector) is favored and is the suggested standard approach 26,27
Not perfect, but easier to roll and more pleasant to smoke
The End-Stage Alcohol Use Disorder: Welcome to the darkest chapter
It could be that exposure to tobacco smoke at a young age increases the risk of respiratory symptoms because the lungs are still developing and more vulnerable to damage
